0001439059-14-000002.txt : 20140327 0001439059-14-000002.hdr.sgml : 20140327 20140326173504 ACCESSION NUMBER: 0001439059-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140327 DATE AS OF CHANGE: 20140326 EFFECTIVENESS DATE: 20140327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AXIKIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439059 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-214321 FILM NUMBER: 14719565 BUSINESS ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-458-1890 MAIL ADDRESS: STREET 1: 10835 ROAD TO THE CURE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0707 D LIVE 0001439059 AXIKIN PHARMACEUTICALS INC 10835 ROAD TO THE CURE SUITE 250 SAN DIEGO CA CALIFORNIA 92121 858-458-1890 DELAWARE None None Corporation true Kevin B. Bacon c/o Axikin Pharmaceuticals Inc. 10835 Road To The Cure, Suite 250 San Diego CA CALIFORNIA 92121 Executive Officer Director Peter C.M. McWilliams c/o Axikin Pharmaceuticals Inc. 10835 Road To The Cure, Suite 250 San Diego CA CALIFORNIA 92121 Executive Officer Director Dan Liu c/o Mitsui & Co. Global Investment, Inc. 535 Middlefield Road, Suite 100 Menlo Park CA CALIFORNIA 94025 Director Fred A. Middleton c/o Sanderling Ventures 400 S. El Camino Real, Suite 1200 San Mateo CA CALIFORNIA 94402 Director Pharmaceuticals Decline to Disclose 06b false 2014-03-12 false true true true false 0 6564103 6000000 564103 This filing includes amounts receivable by the Company upon the exercise of Warrants to purchase shares of the Company's Common Stock, assuming no cashless exercise. Such Warrants have not yet been issued. false 2 0 0 0 false AXIKIN PHARMACEUTICALS INC /S/ Peter C.M. McWilliams Peter C.M. McWilliams Chief Executive Officer 2014-03-26